Limited effectiveness of radioiodine therapy for residual cervical lymph node metastases in radioiodine-naïve papillary thyroid cancer - Scorecard - MDSpire

Limited effectiveness of radioiodine therapy for residual cervical lymph node metastases in radioiodine-naïve papillary thyroid cancer

  • By

  • Seyfettin Ilgan

  • M.Özdeş Emer

  • Ferit Taneri

  • Erdinç Aygenç

  • Serdar Özbaş

  • Murat Akın

  • Erkan Öztürk

  • Banu Bilezikçi

  • Seza A. Gulec

  • July 6, 2026

  • 0 min

Share

Clinical Scorecard: Efficacy of Radioiodine Treatment for Persistent Cervical Lymph Node Metastases in Papillary Thyroid Cancer Patients Without Prior RAI Therapy

At a Glance

CategoryDetail
ConditionPapillary Thyroid Carcinoma (PTC)
Key MechanismsRadioiodine (RAI) therapy targeting cervical lymph node metastases
Target PopulationRAI-naïve patients with structurally confirmed cervical nodal metastases
Care SettingOncology

Key Highlights

  • 39 (26.7%) of cervical lymph node metastases were RAI-avid.
  • Complete response in RAI-avid nodes was 38.5%, while overall response rates were low.
  • RAI-non-avid disease was common, particularly among aggressive histologic subtypes.
  • At patient level, 11% achieved a complete response.
  • Durable treatment effect observed at median follow-up of 77 months.

Guideline-Based Recommendations

Diagnosis

  • Use of serial ultrasonography and biochemical follow-up for treatment response evaluation.

Management

  • RAI therapy is generally recommended for high-risk PTC patients.

Monitoring & Follow-up

  • Follow-up through imaging and biochemical assessments post-RAI therapy.

Risks

  • Potential for persistent biochemical and structural disease despite RAI therapy.

Patient & Prescribing Data

Patients with documented cervical lymph node metastases post-surgery.

RAI therapy may be beneficial for RAI-avid lesions but has modest overall response rates.

Clinical Best Practices

  • Consider a selective, biology-guided approach to RAI therapy.
  • Prioritize reoperative surgical excision for documented structural nodal disease.

Related Resources & Content

Original Source(s)

Limited effectiveness of radioiodine therapy for residual cervical lymph node metastases in radioiodine-naïve papillary thyroid cancer

  • by Seyfettin Ilgan, M.Özdeş Emer, Ferit Taneri, Erdinç Aygenç, Serdar Özbaş, Murat Akın, Erkan Öztürk, Banu Bilezikçi, Seza A. Gulec

  • July 6, 2026

Related Content

Optimizing ciltacabtagene autoleucel outcomes: real-world experience and best practices from a single academic center

A multimodal fusion model integrating Vision Transformer, radiomics, and clinical features for predicting bone metastasis in prostate cancer

Prostate-Specific Antigen Screening Patterns and Metastatic Prostate Cancer in US Veterans